Press release 16 November 2021. Backahill enters into an agreement to sell AB Cernelle. Backahill AB has entered into an agreement to sell all shares in the subsidiary AB Cernelle to the German pharmaceutical group Dermapharm AG. “We have had a long and very interesting time as owners of Cernelle, which has developed very [Read more]
About Pernilla ArbajianThis author has not yet filled in any details.
So far Pernilla Arbajian has created 2 blog entries.
Cernelle enters China. AB Cernelle, in partnership with MeiRui, a leading Chinese pharmaceutical company specialising in urology, has received approval for Shenitong®, which is an herbal medicinal product for the treatment of benign prostate diseases. Both companies are now preparing for the market launch of Shenitong®, with the product expected to be available on [Read more]